A detailed history of Inspire Investing, LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Inspire Investing, LLC holds 40,769 shares of IRWD stock, worth $253,583. This represents 0.04% of its overall portfolio holdings.

Number of Shares
40,769
Previous 33,777 20.7%
Holding current value
$253,583
Previous $386,000 8.03%
% of portfolio
0.04%
Previous 0.04%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$8.32 - $15.45 $58,173 - $108,026
6,992 Added 20.7%
40,769 $355,000
Q4 2023

Feb 12, 2024

BUY
$8.79 - $11.51 $18,529 - $24,263
2,108 Added 6.66%
33,777 $386,000
Q3 2023

Oct 26, 2023

BUY
$8.25 - $11.35 $18,925 - $26,036
2,294 Added 7.81%
31,669 $304,000
Q2 2023

Jul 31, 2023

SELL
$10.1 - $11.6 $458,984 - $527,150
-45,444 Reduced 60.74%
29,375 $312,000
Q1 2023

Apr 24, 2023

BUY
$10.37 - $12.56 $580,284 - $702,832
55,958 Added 296.69%
74,819 $787,000
Q4 2022

Jan 26, 2023

SELL
$9.9 - $12.43 $20,988 - $26,351
-2,120 Reduced 10.1%
18,861 $0
Q3 2022

Nov 07, 2022

BUY
$10.14 - $12.38 $27,276 - $33,302
2,690 Added 14.71%
20,981 $217,000
Q2 2022

Aug 10, 2022

SELL
$11.05 - $12.72 $5,624 - $6,474
-509 Reduced 2.71%
18,291 $211,000
Q1 2022

Apr 21, 2022

SELL
$10.61 - $12.88 $23,511 - $28,542
-2,216 Reduced 10.54%
18,800 $237,000
Q4 2021

Feb 14, 2022

BUY
$10.86 - $13.95 $228,233 - $293,173
21,016 New
21,016 $245,000
Q4 2021

Feb 03, 2022

SELL
$10.86 - $13.95 $189,224 - $243,064
-17,424 Closed
0 $0
Q3 2021

Nov 09, 2021

SELL
$11.92 - $13.92 $140,822 - $164,450
-11,814 Reduced 40.41%
17,424 $228,000
Q2 2021

Aug 10, 2021

BUY
$10.16 - $13.11 $9,001 - $11,615
886 Added 3.13%
29,238 $376,000
Q1 2021

Apr 30, 2021

BUY
$9.04 - $11.86 $78,069 - $102,422
8,636 Added 43.8%
28,352 $317,000
Q4 2020

Feb 12, 2021

BUY
$9.05 - $12.2 $178,429 - $240,535
19,716 New
19,716 $225,000
Q3 2020

Nov 16, 2020

SELL
$8.99 - $10.74 $198,984 - $237,719
-22,134 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$9.14 - $11.97 $6,864 - $8,989
751 Added 3.51%
22,134 $228,000
Q1 2020

May 08, 2020

BUY
$8.58 - $14.01 $72,655 - $118,636
8,468 Added 65.57%
21,383 $216,000
Q4 2019

Jan 24, 2020

SELL
$8.22 - $14.0 $56,085 - $95,522
-6,823 Reduced 34.57%
12,915 $172,000
Q3 2019

Nov 13, 2019

BUY
$8.59 - $10.96 $37,220 - $47,489
4,333 Added 28.13%
19,738 $169,000
Q2 2019

Jul 16, 2019

BUY
$9.8 - $12.89 $39,454 - $51,895
4,026 Added 35.38%
15,405 $169,000
Q1 2019

May 16, 2019

BUY
$8.27 - $12.73 $94,104 - $144,854
11,379 New
11,379 $154,000
Q1 2018

Apr 13, 2018

SELL
$11.13 - $13.63 $38,509 - $47,159
-3,460 Closed
0 $0
Q4 2017

Feb 15, 2018

BUY
$12.16 - $14.58 $42,073 - $50,446
3,460
3,460 $52,000

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $953M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Inspire Investing, LLC Portfolio

Follow Inspire Investing, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Investing, LLC with notifications on news.